|Table of Contents|

Efficacy and safety of RATS versus VATS for lung cancer patients with different body mass index

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 15
Page:
2855-2860
Research Field:
Publishing date:

Info

Title:
Efficacy and safety of RATS versus VATS for lung cancer patients with different body mass index
Author(s):
HONG Ziqiang1; 2; SHENG Yannan1; LU Yingjie1; WU Xusheng1; 2; CHENG Tao1; 2; BAI Xiangdou1; 2; CUI Baiqiang1; 2; JIN Dacheng2; GOU Yunjiu2
1.The First Clinical Department of Gansu University of Traditional Chinese Medicine,Gansu Lanzhou 730000,China;2.Department of Thoracic Surgery,Gansu Provincial Hospital,Gansu Lanzhou 730000,China.
Keywords:
robot-assisted thoracoscopic surgery; video-assisted thoracoscopic surgery; lung cancer; body mass index; propensity score matching analysis
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2023.15.017
Abstract:
Objective:To evaluate the short-term efficacy and safety of robot-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS) for the treatment of lung cancer patients with different body mass indexes(BMI).Methods:Retrospective analysis of 262 minimally invasive surgically treated lung cancer patients who underwent radical lung cancer treatment by RATS (n=122) or VATS (n=140) completed by the same operator in the Department of Thoracic Surgery,Gansu Provincial Hospital from August 2019 to August 2022.Propensity score matching analysis (PSM) was performed for both groups,and then patients were divided into N-BMI group (18.5 kg/m2≤BMI<25 kg/m2) and H-BMI group (BMI≥25 kg/m2) according to their BMI.Compare the patient’s surgery-related data.Results:All patients in both groups successfully completed radical lung cancer surgery with no perioperative deaths.100 patients in each group after PSM.In terms of intraoperative bleeding,postoperative drainage time,postoperative hospital stay,number of lymph nodes dissected and number of lymph nodes dissected groups,the RATS group was more advantageous,and the difference was statistically significant (P＜0.05).In terms of total postoperative chest drainage and hospital cost,the VATS group was more advantageous,and the difference was statistically significant (P＜0.05).In terms of operative time,postoperative complications and intraoperative open heart,the differences between the two groups were not statistically significant (P＞0.05).Subgroup analysis showed that for H-BMI group patients,the RATS group had shorter operative time and lower incidence of postoperative complications,with statistically significant differences (P＜0.05).Conclusion:RATS for lung cancer offers technical and short-term efficacy advantages,but comes with the disadvantage of high costs.Lung cancer patients with high BMI are more suitable for RATS treatment,RATS can achieve better short-term outcomes and safety,especially in terms of reducing the incidence of postoperative complications.

References:

［1］国家癌症中心,国家肿瘤质控中心肺癌质控专家委员会.中国原发性肺癌规范诊疗质量控制指标(2022版)［J］.中华肿瘤杂志,2022,44(7):594-599.National Cancer Center,National Cancer Quality Control Center Lung Cancer Quality Control Expert Committee.Quality control indicators for standardized treatment of primary lung cancer in China (2022 version) ［J］.Chinese Journal of Oncology,2022,44(7):594-599.
［2］YAN TD,BLACK D,BANNON PG,et al.Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer ［J］.J Clin Oncol,2009,27(15):2553-2562.
［3］WEI SY,CHEN MH,CHEN N,et al.Feasibility and safety of robot-assisted thoracic surgery for lung lobectomy in patients with non-small cell lung cancer:a systematic review and meta-analysis ［J］.World J Surg Oncol,2017,15(1):98.
［4］张靖,路璐,王晓楠,等.达芬奇机器人与单孔、三孔胸腔镜肺癌根治术的临床疗效比较［J］.现代肿瘤医学,2020,28(12):2046-2049.ZHANG J,LU L,WANG XN,et al.Comparison of clinical efficacy of da Vinci robot with single- and three-port thoracoscopic radical lung cancer surgery ［J］.Modern Oncology,2020,28(12):2046-2049.
［5］YANG HX,WOO KM,SIMA CS,et al.Long-term survival based on the surgical approach to lobectomy for clinical stage I nonsmall cell lung cancer:Comparison of robotic,video-assisted thoracic surgery,and thoracotomy lobectomy ［J］.Ann Surg,2017,265(2):431-437.
［6］OH DS,REDDY RM,GORREPATI ML,et al.Robotic-assisted,video-assisted thoracoscopic and open lobectomy:Propensity-matched analysis of recent premier data ［J］.Ann Thorac Surg,2017,104(5):1733-1740.
［7］NCD RISC.Trends in adult body-mass index in 200 countries from 1975 to 2014:a pooled analysis of 1 698 population-based measurement studies with 19.2 million participants ［J］.Lancet,2016,387(10026):1377-1396.
［8］NCD RISC.Worldwide trends in body-mass index,underweight,overweight,and obesity from 1975 to 2016:a pooled analysis of 2 416 population-based measurement studies in 128.9 million children,adolescents,and adults ［J］.Lancet,2017,390(10113):2627-2642.
［9］代锋,许世广,徐惟,等.达芬奇机器人与电视胸腔镜辅助非小细胞肺癌根治术近期疗效配对的病例对照研究［J］.中国肺癌杂志,2018,21(3):206-211.DAI F,XU SG,XU W,et al.A paired case controlled study comparing the short-term outcomes of Da Vinci RATS and VATS approach for non-small cell lung cancer ［J］.Chin J Lung Cancer,2018,21(3):206-211.
［10］陶绍霖,康珀铭,谭群友,等.经前侧入路达芬奇机器人辅助肺段切除术的临床分析［J］.中国胸心血管外科临床杂志,2020,27(2):178-182.TAO SL,KANG PM,TAN QY,et al.Experience of robot-assisted lung segmentectomy through anterior approach ［J］.Chinese Clinical Journal of Thoracic and Cardiovascular Surgery,2020,27(2):178-182.
［11］贺生亮,郭天康,柏启州,等.达芬奇机器人系统在高龄患者肺癌根治术中的应用［J］.中国胸心血管外科临床杂志,2021,28(5):514-518.HE SL,GUO TK,BAI QZ,et al.Da Vinci robot system for radical surgery of lung cancer in elderly patients ［J］.Chinese Clinical Journal of Thoracic and Cardiovascular Surgery,2021,28(5):514-518.
［12］胡博潇,刘博,许世广,等.达芬奇机器人与电视胸腔镜辅助手术治疗Ⅰ期肺腺癌远期结果的倾向性评分匹配研究［J］.中国胸心血管外科临床杂志,2020,27(3):284-289.HU BX,LIU B,XU SG,et al.Propensity score matching study of the da Vinci robot and television thoracoscopy-assisted surgery for stage I lung adenocarcinoma with long-term outcomes ［J］.Chinese Clinical Journal of Thoracic and Cardiovascular Surgery,2020,27(3):284-289.
［13］PAUL S,SEDRAKYAN A,CHIU YL,et al.Outcomes after lobectomy using thoracoscopy vs thoracotomy:a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database ［J］.Eur J Cardiothorac Surg,2013,43(4):813-817.
［14］PAUL S,ALTORKI NK,SHENG S,et al.Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy:a propensity-matched analysis from the STS database ［J］.J Thorac Cardiovasc Surg,2010,139(2):366-378.
［15］杜宁彬,王伟峰,王猛,等.达芬奇机器人手术、胸腔镜手术及开胸手术治疗早期肺癌的疗效对比［J］.现代肿瘤医学,2019,27(11):1915-1917.DU NB,WANG WF,WANG M,et al.Comparison of the efficacy of da Vinci robotic surgery,thoracoscopic surgery and open-heart surgery for early-stage lung cancer ［J］.Modern Oncology,2019,27(11):1915-1917.
［16］王述民.达芬奇机器人在肺癌根治术中的应用现状及展望［J］.中国肿瘤,2014,23(9):736-742.WANG SM.Current status and outlook of da Vinci robot in radical lung cancer surgery ［J］.China Oncology,2014,23(9):736-742.
［17］WEE I,KUO LJ,NGU J.The impact of robotic colorectal surgery in obese patients:a systematic review,meta-analysis,and meta-regression ［J］.Surg Endosc,2019,33(11):3558-3566.
［18］高庚妹,陈兰,李太原,等.机器人与腹腔镜直肠癌根治术治疗超重和肥胖患者的疗效对比分析［J］.中华胃肠外科杂志,2021,24(01):68-74.GAO GM,CHEN L,LI TY,et al.Comparative analysis of the efficacy of robotic versus laparoscopic radical rectal cancer treatment for overweight and obese patients ［J］.Chinese Journal of Gastrointestinal Surgery,2021,24(01):68-74.
［19］王朋飞.应用倾向评分匹配法评价术前体重指数对非小细胞肺癌围手术期及远期预后的影响［D］.兰州:兰州大学,2020.WANG PF.Application of propensity score matching method to evaluate the impact of preoperative body mass index on perioperative and long-term prognosis of non-small cell lung cancer ［D］.Lanzhou:Lanzhou University,2020.
［20］NELSON DB,MEHRAN RJ,MITCHELL KG,et al.Robotic-assisted lobectomy for non-small cell lung cancer:A comprehensive institutional experience ［J］.Ann Thorac Surg,2019,108(2):370-376.
［21］LI JT,LIU PY,HUANG J,et al.Perioperative outcomes of radical lobectomies using robotic-assisted thoracoscopic technique vs.video-assisted thoracoscopic technique:retrospective study of 1 075 consecutive p-stage I non-small cell lung cancer cases ［J］.J Thorac Dis,2019,11(3):882-891.
［22］LI C,HU Y,HUANG J,et al.Comparison of robotic-assisted lobectomy with video-assisted thoracic surgery for stage IIb-IIIa non-small cell lung cancer ［J］.Transl Lung Cancer Res,2019,8(6):820-828.
［23］KNEUERTZ PJ,CHEUFOU DH,D’ SOUZA DM,et al.Propensity-score adjusted comparison of pathologic nodal upstaging by robotic,video-assisted thoracoscopic,and open lobectomy for non-small cell lung cancer ［J］.J Thorac Cardiovasc Surg,2019,158(5):1457-1466.
［24］SHEN C,CHE GW.Tubeless minimally invasive treatment:taking a new step in enhanced recovery after surgery (ERAS) ［J］.Thorac Cancer,2019,10(11):2067-2070.
［25］WU DH,LIANG HR,LIANG WH,et al.Spontaneous ventilation video-assisted thoracoscopic surgery for patients with non-small-cell lung cancer with excess body weight ［J］.Eur J Cardiothorac Surg,2020,58(3):605-612.
［26］SEDER CW,FARROKHYAR F,NAYAK R,et al.Robotic vs thoracoscopic anatomic lung resection in obese patients:A propensity-adjusted analysis ［J］.Ann Thorac Surg,2021,S0003-4975(21):01837-3.
［27］LI SJ,WANG ZQ,HUANG J,et al.Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery:does the ’obesity paradox’ really exist［J］.Eur J Cardiothorac Surg,2017,51(5):817-828.
［28］VALENTIJN TM,GALAL W,TJEERTES E,et al.The obesity paradox in the surgical population ［J］.Surgeon,2013,11(3):169-176.
［29］BHUIYAN MU.Preoperative assessment of serum albumin level as risk factor for morbidity following routine oncological surgery ［J］.Mymensingh Med J,2016,25(2):277-283.

Memo

Memo:
甘肃省重点研发项目（编号：22YF7FA095）；甘肃省卫生健康行业科研计划项目（编号：GSWSKY2020-50）
Last Update: 2023-06-30